Pasithea Therapeutics Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Pasithea Therapeutics shares have resumed trading after a temporary halt. The resumption of trading allows investors to buy and sell Pasithea Therapeutics stock once again.

January 02, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pasithea Therapeutics shares have resumed trading, which could lead to increased volatility as investors react to the resumption.
The resumption of trading typically leads to a normalization of stock activity. However, depending on the reasons behind the trading halt, there could be increased volatility. Without specific information on why trading was halted or what developments occurred during the halt, it is difficult to predict the direction of the stock price. Therefore, a neutral score is given.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100